Cutaneous Surgery Outcomes in Patients on Epidermal Growth Factor Receptor Inhibitors

Dermatol Surg. 2021 Nov 1;47(11):1519-1521. doi: 10.1097/DSS.0000000000003214.

Authors

Michelle A Robinson¹, Anisha B Patel^{2

3}, Kelly M Wilmas², Valencia Thomas³, Meghan Heberton³

Affiliations

¹ John P. and Katherine G. McGovern Medical School, Houston, Texas.
² Department of Dermatology, John P. and Katherine G. McGovern Medical School, Houston, Texas.
³ Department of Dermatology, MD Anderson Cancer Center, Houston, Texas.

PMID: 34417386
DOI: 10.1097/DSS.0000000000003214

No abstract available

MeSH terms

Aged
Aged, 80 and over
Dermatologic Surgical Procedures*
ErbB Receptors / antagonists & inhibitors*
Female
Humans
Male
Middle Aged
Postoperative Complications / epidemiology*
Retrospective Studies
Skin Neoplasms / surgery*
Treatment Outcome
Wound Healing / drug effects*

Substances

ErbB Receptors